Bosh sahifa069620 • KRX
add
Daewoong Pharma
Yopilish kursi
164 600,00 ₩
Kunlik diapazon
164 000,00 ₩ - 167 800,00 ₩
Yillik diapazon
109 000,00 ₩ - 199 400,00 ₩
Bozor kapitalizatsiyasi
1,94 trln KRW
Oʻrtacha hajm
42,29 ming
Narx/foyda
20,63
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 411,83 mlrd | 14,88% |
Joriy xarajat | 156,83 mlrd | 8,36% |
Sof foyda | 46,37 mlrd | 63,95% |
Sof foyda marjasi | 11,26 | 42,71% |
Har bir ulushga tushum | — | — |
EBITDA | 69,45 mlrd | 41,15% |
Amaldagi soliq stavkasi | 13,56% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 208,62 mlrd | 94,04% |
Jami aktivlari | 2,26 trln | 17,58% |
Jami passivlari | 1,22 trln | 25,77% |
Umumiy kapital | 1,04 trln | — |
Tarqatilgan aksiyalar | 11,51 mln | — |
Narxi/balansdagi bahosi | 2,15 | — |
Aktivlardan daromad | 6,51% | — |
Kapitaldan daromad | 8,00% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 46,37 mlrd | 63,95% |
Operatsiyalardan naqd pul | 57,53 mlrd | 159,07% |
Sarmoyadan naqd pul | -73,82 mlrd | -42,84% |
Moliyadan naqd pul | 57,48 mlrd | 57,12% |
Naqd pulning sof oʻzgarishi | 44,69 mlrd | 548,42% |
Boʻsh pul | -12,48 mlrd | 64,80% |
Haqida
Daewoong Pharmaceutical Co., Ltd. is a pharmaceutical company headquartered in Seoul, South Korea. Daewoong Pharmaceutical primarily engages in the manufacture of pharmaceutical products, including prescription and over-the-counter healthcare products. Wikipedia
Tashkil etilgan
1945
Sayt
Xodimlar soni
1 644
